This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Tucker, S. Search for Related Content PubMed Articles by Tucker, S.

Cost Savings and Luteinizing Hormone–Releasing Hormone Agonist

Because this article has no abstract, we have provided an extract of the first 20% of the full text.

Steven Tucker, MD

In the March 2006 issue of the Journal of Oncology Practice, Wagmiller et al¹ describe significant potential cost savings for use of an individualized luteinizing hormone-releasing hormone agonist (LH-RHa) strategy based on serum testosterone triggers rather than strict manufacturer guidelines. It is clear and well documented that gonadal suppression persists for months after LH-RHa therapy is held, and even minimal androgen recovery may be delayed by more than . . . [Click for More]